For blood cancers the two things that change outcomes are an accurate diagnosis and access to the right therapy at the right moment. China's top haematology centres see enormous case volumes, and carry the full range of options in one place.
Acute and chronic leukaemias, including relapsed and refractory disease, and patients who have already exhausted standard protocols.
Hodgkin and non-Hodgkin lymphoma, including diffuse large B-cell lymphoma after multiple lines of treatment.
Relapsed myeloma, including BCMA-targeted CAR-T and access to trials of next-generation agents.
A haematopathologist who sees a rare subtype every month reads a bone marrow slide differently from one who sees it once a year. That is not a criticism of any individual doctor — it is simply what volume does. The top haematology centres in Beijing, Shanghai and Chengdu are among the busiest in the world.
This is the single strongest argument for a second opinion even if you ultimately treat at home. The written report is yours to take back to your own oncologist.
We read what you send and identify gaps.
Licensed haematologists review the case.
Options, costs and a timeline you can act on.
Only if you decide to go, and not before.
No commitment, no fee. If China is not the right answer for your case, we will tell you that first.
What to send: diagnosis, most recent pathology report, treatment history, and latest imaging. Reply within 48 hours.
